reserpine has been researched along with labetalol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Vidt, DG | 1 |
| Lubbe, WF | 1 |
| Drayer, JI; Weber, MA | 1 |
| Endo, J; Ohshika, H; Takemura, H; Tanaka, M | 1 |
| Jacobson, AF; Travin, MI | 1 |
4 review(s) available for reserpine and labetalol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hypertension in pregnancy. Pathophysiology and management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clonidine; Diazoxide; Diuretics; Drug Therapy, Combination; Female; Fetal Diseases; Hemodynamics; Humans; Hydralazine; Hypertension; Hypnotics and Sedatives; Labetalol; Magnesium Sulfate; Pregnancy; Pregnancy Complications, Cardiovascular; Reserpine; Sympatholytics; Tranquilizing Agents | 1984 |
Central and peripheral blockade of the sympathetic nervous system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Guanabenz; Humans; Hypertension; Indoramin; Labetalol; Methyldopa; Prazosin; Quinazolines; Reserpine; Sympathetic Nervous System; Sympatholytics | 1984 |
Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature.
Topics: 3-Iodobenzylguanidine; Amines; Amiodarone; Animals; Anti-Arrhythmia Agents; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Cardiology; Cell Line; Cell Line, Tumor; Diagnostic Imaging; Drug Interactions; Heart; Heart Failure; Humans; Iodine Radioisotopes; Labetalol; Norepinephrine; Radiopharmaceuticals; Receptors, Adrenergic; Reproducibility of Results; Reserpine; Risk; Selective Serotonin Reuptake Inhibitors; Sympathetic Nervous System | 2015 |
7 other study(ies) available for reserpine and labetalol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Current concepts in treatment of hypertensive emergencies.
Topics: Diazoxide; Drug Therapy, Combination; Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nitroglycerin; Nitroprusside; Phentolamine; Reserpine; Sympathomimetics; Trimethaphan; Vasodilator Agents | 1986 |
Potentiation of isoproterenol-induced salivation by labetalol.
Topics: Amylases; Animals; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Ethanolamines; Hydroxydopamines; In Vitro Techniques; Isoproterenol; Labetalol; Male; Oxidopamine; Parotid Gland; Potassium; Rats; Rats, Inbred Strains; Reserpine; Salivation | 1982 |